Breathe Well Live Well
|
Use of long-acting bronchodilators, inhaled corticosteroids in children with asthma
Healio Read comments from an expert whom Infectious Diseases in Children spoke with regarding ongoing concerns over the safety of asthma medications. We welcome you to share your own impression of the common misconceptions associated with asthma … |
View full post on asthma – Google News
ModernMedicine |
Small-particle inhaled corticosteroids: Paradigm shift in asthma treatment
ModernMedicine When large-particle inhaled corticosteroids (ICS) used as a monotherapy fail to control asthma, the current asthma guidelines recommend “stepping up” therapy by adding long-acting beta 2 agonists (LABAs) to the regimen as a first-line alternative … |
View full post on asthma – Google News
|
Non-adherence to inhaled corticosteroids and the risk of asthma exacerbations in children
Dove Medical Press Background: Non-adherence to inhaled corticosteroids (ICSs) is a major risk factor for poor asthma control in children. However, little is known about the effect of adherence to ICS on the incidence of asthma exacerbations. The objective of this study … |
View full post on asthma – Google News
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Other: ICS withdrawal; Other: Usual care
Sponsors: Radboud University; Novartis; Boehringer Ingelheim
Recruiting – verified February 2016
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: beclomethasone; Drug: fluticasone
Sponsor: University of Virginia
Not yet recruiting – verified October 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
|
Why Corticosteroids Poorly Control Severe Asthma
Pharmacy Times The approximate 1 in 10 asthma patients who have severe disease do not respond to mainstay corticosteroid treatment, even in high doses. That could be because the immune response that occurs in the airways of severe asthma patients markedly differs … |
View full post on asthma – Google News
Lung Disease News |
VNN1 Gene Could Serve As a Biomarker for Response to Corticosteroids in …
Lung Disease News According to study investigator Gurjit Khurana Hershey, MD, PhD, director of Asthma Research at Cincinnati Children's Hospital Medical Center, “Genome-wide analysis allowed us to identify a gene, whose expression discriminated between good and poor … |
View full post on asthma – Google News
Condition: Healthy
Interventions: Drug: Fluticasone propionate; Device: Accuhaler
Sponsors: University Hospitals, Leicester; Genentech,Inc., South San Francisco, USA
Not yet recruiting – verified June 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: Fluticasone Furoate; Drug: Vilanterol; Drug: Fluticasone propionate; Drug: Salmeterol; Drug: Budesonide; Drug: Formoterol Fumarate
Sponsor: GlaxoSmithKline
Not yet recruiting – verified May 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Biological: Tralokinumab; Other: Placebo
Sponsor: AstraZeneca
Not yet recruiting – verified May 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days